Drug Development

Articles

These models are useful in predicting whether an unknown substance of abuse can permeate the BBB to produce effects predicted by the Public Health Assessment via Structural Evaluation (PHASE) approach.

New QSAR Model for Predicting Blood Brain Barrier Permeability

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.

Exploring Foreign Epitopes Recogniton in Personalized Medicines with Vibha Jawa

Feliza Mirasol is the science editor for 

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.



Ramping Up Nucleic Acid Therapy Development

E&L analytical testing methods can be determined through pointed consideration of the differences small- and large-molecule drug products.

E&L Analytical Testing Considerations

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Process control is essential for using continuous hot-melt extrusion to enhance solubility.

Continuous Hot-Melt Extrusion for Poorly Soluble APIs

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Podcasts

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Gregor Kawaletz, head of Oral Solid Dose Business Unit at Recipharm, discusses the immediate future of oral biologics

Diving Deep into Oral Biologics with Gregor Kawaletz (DCAT 2023)

Jaeger notes that the program is focused on addressing specific scientific questions that will produce immediate impacts on how CDER and FDA make drug approval decisions.

FDA’s Office of New Drugs Highlights New Research Projects for Growth 

The recent success of mRNA vaccines has opened the door for further and future development of nucleic acid-based therapies.

Nucleic Acid-based Therapeutics Are Stepping into the Spotlight

Actions combatting the next pandemic must be diverse, reliable, and sustainable.

Formulation and Drug Delivery